Abstract:Key points Smooth muscle myosin regulatory light chain (RLC) phosphorylation depends on the relative activities of myosin light chain kinase (MLCK), activated by Ca2+–calmodulin, and myosin light chain phosphatase (MLCP). MYPT1 is a scaffolding protein subunit of MLCP that binds the catalytic subunit PP1cδ and myosin, affects the conformation of PP1cδ for effective inhibition by phosphorylated CPI‐17, and is phosphorylated at two sites that inhibit PP1cδ activity. A conditional knockout of MYPT1 in smooth muscles of adult mice resulted in modest changes in bladder smooth muscle contractile and relaxation responses to KCl or carbachol even though the amount of PP1cδ protein was reduced. A new a procedure to quantify phosphorylation of MYPT1 showed substantial phosphorylation in wild‐type tissues under resting conditions, predicting attenuation of MLCP activity. Reduced PP1cδ activity in MYPT1‐deficient tissues may be similar to the attenuated MLCP activity in wild‐type tissues resulting from constitutively phosphorylated MYPT1. In contrast to results obtained with the conditional knockout of MLCK in smooth muscle, MYPT1 is not necessary for smooth muscle function because its loss may not change the effective MLCP activity. AbstractSmooth muscle contraction initiated by myosin regulatory light chain (RLC) phosphorylation is dependent on the relative activities of Ca2+–calmodulin‐dependent myosin light chain kinase (MLCK) and myosin light chain phosphatase (MLCP). We have investigated the physiological role of the MLCP regulatory subunit MYPT1 in bladder smooth muscle containing a smooth muscle‐specific deletion of MYPT1 in adult mice. Deep‐sequencing analyses of mRNA and immunoblotting revealed that MYPT1 depletion reduced the amount of PP1cδ with no compensatory changes in expression of other MYPT1 family members. Phosphatase activity towards phosphorylated smooth muscle heavy meromyosin was proportional to the amount of PP1cδ in total homogenates from wild‐type or MYPT1‐deficient tissues. Isolated MYPT1‐deficient tissues from MYPT1SM−/− mice contracted with moderate differences in response to KCl and carbachol treatments, and relaxed rapidly with comparable rates after carbachol removal and only 1.5‐fold slower after KCl removal. Measurements of phosphorylated proteins in the RLC signalling and actin polymerization modules during contractions revealed moderate changes. Using a novel procedure to quantify total phosphorylation of MYPT1 at Thr696 and Thr853, we found substantial phosphorylation in wild‐type tissues under resting conditions, predicting attenuation of MLCP activity. Reduced PP1cδ activity in MYPT1‐deficient tissues may be similar to the attenuated MLCP activity in wild‐type tissues resulting from constitutively phosphorylated MYPT1. Constitutive phosphorylation of MYPT1 Thr696 and Thr853 may thus represent a physiological mechanism acting in concert with agonist‐induced MYPT1 phosphorylation to inhibit MLCP activity. In summary, MYPT1 deficiency may not cause significant derangement of smooth muscle contractility because the effective MLCP activity is not changed.

PTP1B Triggers Integrin-Mediated Repression of Myosin Activity and Modulates Cell Contractility

Protein tyrosine phosphatase PTP1B in cell adhesion and migration

Phosphorylated α-Actinin and Protein-tyrosine Phosphatase 1B Coregulate the Disassembly of the Focal Adhesion Kinase·Src Complex and Promote Cell Migration

PTP1B inhibitor promotes endothelial cell motility by activating the DOCK180/Rac1 pathway

Protein Tyrosine Phosphatase-PEST and Β8 Integrin Regulate Spatiotemporal Patterns of RhoGDI1 Activation in Migrating Cells

PTP1B phosphatase dampens iPSC-derived neutrophil motility and antimicrobial function

β1,6 GlcNAc branches-modified protein tyrosine phosphatase alpha enhances its stability and promotes focal adhesion formation in MCF-7 cells

Inhibition of myosin/moesin phosphatase by expression of the phosphoinhibitor protein CPI-17 alters microfilament organization and retards cell spreading

Kon-tiki enhances PS2 integrin adhesion and localizes its ligand, Thrombospondin, in the myotendinous junction

Atypical Peripheral Actin Band Formation Via Overactivation of RhoA and Nonmuscle Myosin II in Mitofusin 2-Deficient Cells

Evidence for Regulation of the Tumor Necrosis Factor Α-Convertase (TACE) by Protein-tyrosine Phosphatase PTPH1

Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases.

In Vivo Roles for Myosin Phosphatase Targeting Subunit-1 Phosphorylation Sites T694 and T852 in Bladder Smooth Muscle Contraction.

Type I Phosphatidylinositol Phosphate Kinase Beta Regulates Focal Adhesion Disassembly by Promoting Beta 1 Integrin Endocytosis

PTEN As an Effector in the Signaling of Antimigratory G Protein-Coupled Receptor

Constitutive Phosphorylation of Myosin Phosphatase Targeting Subunit-1 in Smooth Muscle.

Protein tyrosine phosphatase 1B is a regulator of alpha-actinin4 in the glomerular podocyte

Myosin Phosphatase Target Subunit 1 (MYPT1) Regulates the Contraction and Relaxation of Vascular Smooth Muscle and Maintains Blood Pressure

PCTK3/CDK18 regulates cell migration and adhesion by negatively modulating FAK activity

Pleiotrophin Activates cMet- and mTORC1-Dependent Protein Synthesis through PTPRZ1—The Role of ανβ3 Integrin

Protein Tyrosine Phosphatase 1B Regulates Fibroblasts Proliferation, Motility and Extracellular Matrix Synthesis Via the MAPK/ERK Signalling Pathway in Keloid.